Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · operational-macro

Thomas J. Appio Named Interim CEO of Bausch + Lomb as Brent Saunders Departs

12 October 2026 · By · Wire by Fusion42

Published

12 October 2026

Topic

operational-macro

◆ Sectors

Health

◆ Geography

United States

◆ Source

Read at visionmonday.com →

◆ Verified

Fusion42 · 13 October 2026 · Fusion42 review

Thomas J. Appio was named interim CEO of Bausch + Lomb, replacing Brent Saunders who departed by mutual agreement, as the company aims to build on its growth momentum under Appio's leadership.

This Wire brief sits within Fusion42's coverage of Health, and 3 sources have reported it.

◆ ◆ The Wire takeaway

Your healthtech company needs stable leadership to maintain growth amid this executive shuffle. Appio’s dual role signals a tight link between parent and subsidiary strategies, so prepare for aligned operational shifts.

◆ Coverage

3 sources · 12 Oct 2026

◆ Related on Wire

◆ Topics

Healthexecutive-changeleadershiphealthcarecorporate-governancegrowth